Michael P. Dubé

4.3k total citations
96 papers, 3.2k citations indexed

About

Michael P. Dubé is a scholar working on Infectious Diseases, Emergency Medicine and Virology. According to data from OpenAlex, Michael P. Dubé has authored 96 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Infectious Diseases, 45 papers in Emergency Medicine and 39 papers in Virology. Recurrent topics in Michael P. Dubé's work include HIV-related health complications and treatments (45 papers), HIV Research and Treatment (39 papers) and HIV/AIDS Research and Interventions (30 papers). Michael P. Dubé is often cited by papers focused on HIV-related health complications and treatments (45 papers), HIV Research and Treatment (39 papers) and HIV/AIDS Research and Interventions (30 papers). Michael P. Dubé collaborates with scholars based in United States, Canada and Italy. Michael P. Dubé's co-authors include Judith S. Currier, James H. Stein, Richard Haubrich, Carol A. Kemper, Donald N. Forthal, J. Allen McCutchan, Susan J. Little, Todd T. Brown, Debra Johnson and Grace A. McComsey and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Michael P. Dubé

93 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael P. Dubé United States	33	1.9k	1.5k	1.2k	926	277	96	3.2k
Roger Bedimo United States	26	1.5k 0.8×	1.1k 0.7×	646 0.6×	798 0.9×	354 1.3×	90	2.8k
Carsten Schade Larsen Denmark	33	2.0k 1.1×	1.4k 1.0×	1.1k 1.0×	1.2k 1.3×	260 0.9×	176	4.0k
Sharon A. Riddler United States	34	2.9k 1.5×	1.8k 1.2×	2.6k 2.2×	751 0.8×	155 0.6×	95	4.4k
Rohan Hazra United States	39	2.7k 1.4×	1.5k 1.0×	1.1k 0.9×	1.1k 1.2×	219 0.8×	134	4.1k
Frank A. Post United Kingdom	38	3.6k 1.9×	2.1k 1.5×	1.3k 1.1×	1.6k 1.8×	414 1.5×	185	4.8k
Eugènia Negredo Spain	39	3.2k 1.7×	1.9k 1.3×	2.5k 2.2×	804 0.9×	158 0.6×	186	4.8k
José L. Casado Spain	31	2.3k 1.2×	777 0.5×	1.3k 1.2×	1.3k 1.4×	177 0.6×	189	3.7k
Ferdinand W.N.M. Wit Netherlands	34	2.2k 1.1×	1.5k 1.0×	1.8k 1.5×	1.0k 1.1×	92 0.3×	109	3.6k
Kathleen C. Wood United States	20	2.2k 1.1×	1.5k 1.0×	1.2k 1.0×	1.3k 1.4×	230 0.8×	29	3.3k
Ana Guelar Spain	24	1.2k 0.6×	789 0.5×	542 0.5×	639 0.7×	316 1.1×	48	2.0k

Countries citing papers authored by Michael P. Dubé

Since Specialization

Citations

This map shows the geographic impact of Michael P. Dubé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael P. Dubé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael P. Dubé more than expected).

Fields of papers citing papers by Michael P. Dubé

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael P. Dubé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael P. Dubé. The network helps show where Michael P. Dubé may publish in the future.

Co-authorship network of co-authors of Michael P. Dubé

This figure shows the co-authorship network connecting the top 25 collaborators of Michael P. Dubé. A scholar is included among the top collaborators of Michael P. Dubé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael P. Dubé. Michael P. Dubé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dubé, Michael P., et al.. (2023). What Drives Evolution of Self-Driving Automata?. 1 indexed citations

Patel, Nimish, et al.. (2022). Method of Calculating Renal Function Estimates Could Inappropriately Exclude Transgender Patients Receiving Gender-Affirming Hormone Therapy from Pre-Exposure Prophylaxis Eligibility. LGBT Health. 9(3). 199–206. 2 indexed citations

Presti, Rachel M., Brett Williams, Alan Landay, et al.. (2021). A Randomized, Placebo-Controlled Trial Assessing the Effect of VISBIOME ES Probiotic in People With HIV on Antiretroviral Therapy. Open Forum Infectious Diseases. 8(12). ofab550–ofab550. 12 indexed citations

Pasipanodya, Elizabeth, Michael J. Li, Sonia Jain, et al.. (2020). Greater Levels of Self-Reported Adherence to Pre-Exposure Prophylaxis (PrEP) are Associated with Increased Condomless Sex Among Men Who Have Sex with Men. AIDS and Behavior. 24(11). 3192–3204. 10 indexed citations

Hoenigl, Martin, David J. Moore, Peter L. Anderson, et al.. (2019). Predictors of Long-Term HIV Pre-exposure Prophylaxis Adherence After Study Participation in Men Who Have Sex With Men. JAIDS Journal of Acquired Immune Deficiency Syndromes. 81(2). 166–174. 17 indexed citations

Sun, Xiaoying, Sheldon Morris, Stan G. Louie, et al.. (2019). Effect of Vitamin D Supplementation on Bone Turnover Markers During HIV Pre-Exposure Prophylaxis Using Tenofovir Disoproxil Fumarate-Emtricitabine in Men Who Have Sex with Men. AIDS Research and Human Retroviruses. 35(7). 608–614. 4 indexed citations

Blumenthal, Jill, Michael P. Dubé, Eric Ellorin, et al.. (2018). Effect of rectal douching/enema on rectal gonorrhoea and chlamydia among a cohort of men who have sex with men on HIV pre-exposure prophylaxis. Sexually Transmitted Infections. 94(7). 508–514. 12 indexed citations

Dysangco, Andrew, Ziyue Liu, James H. Stein, Michael P. Dubé, & Samir K. Gupta. (2017). HIV infection, antiretroviral therapy, and measures of endothelial function, inflammation, metabolism, and oxidative stress. PLoS ONE. 12(8). e0183511–e0183511. 32 indexed citations

Dubé, Michael P., Lauren Komarow, Carl J. Fichtenbaum, et al.. (2015). Extended-Release Niacin Versus Fenofibrate in HIV-Infected Participants With Low High-Density Lipoprotein Cholesterol: Effects on Endothelial Function, Lipoproteins, and Inflammation. Clinical Infectious Diseases. 61(5). 840–849. 13 indexed citations

10.

Beliakova‐Bethell, Nadejda, Sonia Jain, Christopher H. Woelk, et al.. (2014). Maraviroc intensification in patients with suppressed HIV viremia has limited effects on CD4+ T cell recovery and gene expression. Antiviral Research. 107. 42–49. 11 indexed citations

11.

Gupta, Samir K., Deming Mi, Sharon M. Moe, Michael P. Dubé, & Ziyue Liu. (2013). Effects of Switching from Efavirenz to Raltegravir on Endothelial Function, Bone Mineral Metabolism, Inflammation, and Renal Function: A Randomized, Controlled Trial. IUScholarWorks (Indiana University). 2 indexed citations

12.

Grant, P. M., Douglas Kitch, Grace A. McComsey, et al.. (2013). Low Baseline CD4+ Count Is Associated With Greater Bone Mineral Density Loss After Antiretroviral Therapy Initiation. Clinical Infectious Diseases. 57(10). 1483–1488. 86 indexed citations

13.

Gupta, Samir K., Changyu Shen, Sharon M. Moe, et al.. (2012). Worsening Endothelial Function with Efavirenz Compared to Protease Inhibitors: A 12-Month Prospective Study. PLoS ONE. 7(9). e45716–e45716. 34 indexed citations

14.

Dubé, Michael P. & Joseph Cadden. (2011). Lipid Metabolism in Treated HIV Infection. Best Practice & Research Clinical Endocrinology & Metabolism. 25(3). 429–442. 36 indexed citations

15.

Shankar, Sudha S., Michael P. Dubé, J. Christopher Gorski, James E. Klaunig, & Helmut O. Steinberg. (2005). Indinavir impairs endothelial function in healthy HIV-negative men. American Heart Journal. 150(5). 933.e1–933.e7. 77 indexed citations

16.

Aberg, Judith A., Paige L. Williams, Tun Liu, et al.. (2003). A Study of Discontinuing Maintenance Therapy in Human Immunodeficiency Virus–Infected Subjects with DisseminatedMycobacterium aviumComplex: AIDS Clinical Trial Group 393 Study Team. The Journal of Infectious Diseases. 187(7). 1046–1052. 27 indexed citations

17.

Haubrich, Richard, Susan J. Little, Judith S. Currier, et al.. (1999). The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. AIDS. 13(9). 1099–1107. 472 indexed citations

18.

Dubé, Michael P. & Fred R. Sattler. (1998). Metabolic complications of antiretroviral therapies.. PubMed. 10(6). 41–4. 38 indexed citations

19.

Dubé, Michael P., Fred R. Sattler, Francesca J. Torriani, et al.. (1997). A Randomized Evaluation of Ethambutol for Prevention of Relapse and Drug Resistance during Treatment ofMycobacterium aviumComplex Bacteremia with Clarithromycin‐Based Combination Therapy. The Journal of Infectious Diseases. 176(5). 1225–1232. 65 indexed citations

20.

Dubé, Michael P., Paul Holtom, & Robert A. Larsen. (1992). Tuberculous meningitis in patients with and without human immunodeficiency virus infection. The American Journal of Medicine. 93(5). 520–524. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact